Tag Archives : Granulomatosis with polyangiitis

Breakthrough Therapy for Patients with Giant Cell Arteritis

FDA Grants Breakthrough Therapy Designation for GENENTECH’S Actemra® (tocilizumab) in Giant Cell Arteritis, A form of vasculitis Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced more »


Read More

Support the VF through the Amazon Smile Program

Just in time for your holiday shopping! AmazonSmile is a simple and automatic way for you to support the Vasculitis Foundation every time you shop, at no cost to you. more »


Read More

Brandon Qualifies for the 1500m Semi-Finals – Competes July 8th

Brandon Hudgins, elite runner, and vasculitis patient, continues his quest to make the 2016 U.S. Olympic Team!  On Thursday, July 7th, Brandon qualified for the semi-finals of the 1500m race more »


Read More

KU Vasculitis Symposium – August 6 – Register Today

The Vasculitis Foundation is pleased to partner with the University of Kansas Medical Center to present the 2016 Vasculitis Symposium Educational Conference.  The one-day meeting will be held on Saturday, more »


Read More

VF Breaks $2,000,000 in Research Funding

In February, the VF Board of Directors approved three new research studies for funding, bringing to a total, $2,109,847,10, the VF has committed to supporting vasculitis research since 2002.  The more »


Read More